These drugs mimic the effects of a hormone called glucagon-like peptide-1, which regulates blood sugar levels by stimulating insulin secretion and reducing the production of glucagon, a hormone that increases blood sugar levels
Venture Partners at CU Boulder and CU Innovations at CU Anschutz helped launch more than 35 startups and finalize over 90 licensing agreements
Our obesity and cardiometabolic care delivers: Better engagement Better outcomes Lower total cost of care Learn how Form Health can support your workforce with evidence-based obesity and cardiometabolic care: To view or add a comment, sign in This case series demonstrates foveal hypoplasia as a confounding factor in the diagnosis of amblyopia in three pediatric patients
Additionally, a multi-country study found substantial demand for GLP-1 medications among people without medical indications, highlighting the evolving landscape of body image and obesity treatment (Jensen et al., 2025)
Reports from Medical Sources Several trusted medical websites and health organizations list fast heartbeat or irregular heartbeat as a possible side effect of tirzepatide